AS
Ascletis Pharma Inc.
ASCLF · OTC
$1.20 -0.83% (-$0.01)
1M -7.69%
Market Cap ¥8.42B
P/E Ratio -
Div. Yield -
ROE 17.44%
Piotroski F-Score Weak
1/9Valuation
23 /100
Expensive P/S 4,263.77x
P/B 4.35x
P/E N/A
Growth
0 /100
Declining Rev. growth 66.82%
Book val. growth 8.66%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 842.70%
FCF margin 16,746.40%
Net margin 17,745.60%
Quality
0 /100
Poor ROIC 24.25%
Asset turnover 0.00x
ROE 17.44%
Debt
69 /100
Low Debt/Equity 0.00x
Int. coverage -2,949.78x
Current ratio 15.05x
Stability
13 /100
Unstable Beta 0.39x
Profitable years 0
Rev. volatility 77.39%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ASCLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jinzi J. Wu
Employees
202
Headquarters
Hangzhou
Upcoming events
30 MAR
Earnings
Upcoming earnings report